Figure 4.

(a) Univariate Kaplan–Meier analysis of progression-free survival identifies lincRNAs associated with good/poor prognosis (event free survival) in PCPG molecular subtypes. (b) Combined prognostic score for 18 lincRNA signature (13 lincRNAs from Table 1 and five lincRNAs from Fig. 4a) and 7 previously reported clinical parameters (SDHB germline mutation, ATRX somatic mutation, extra-adrenal tumor location, TERT expression representing telomerase activation and hormone profiles) for prediction of metastasis-free survival from PCPG clinical samples from TCGA.